Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism CDK2 inhibitors(Cyclin-dependent kinase 2 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Preclinical | United States | 30 Sep 2020 | |
Solid tumor | Preclinical | China | 30 Sep 2020 |